标普生物科技LOF(161127)利润分配表
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
| 收入 |
-23,008,527.05 |
10,021,686.71 |
13,922,048.78 |
28,723,250.61 |
| 利息合计 |
30,542.78 |
85,921.63 |
50,918.51 |
53,960.32 |
| 其中:存款利息收入 |
30,542.78 |
85,921.63 |
50,918.51 |
53,960.32 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
-243,521.67 |
28,783,168.22 |
17,648,566.76 |
-11,030,004.15 |
| 其中:股票投资收益 |
-582,981.22 |
28,254,159.75 |
17,485,281.70 |
-11,335,045.82 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
- |
- |
- |
- |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
339,459.55 |
529,008.47 |
163,285.06 |
305,041.67 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
-22,285,370.07 |
-19,161,540.87 |
-4,052,692.95 |
39,267,737.57 |
| 其他收入 |
5,459.86 |
31,700.12 |
1,443.98 |
15,897.56 |
| 费用 |
1,693,042.31 |
3,735,072.37 |
1,864,038.51 |
3,600,082.58 |
| 管理人报酬 |
1,230,636.11 |
2,536,979.91 |
1,256,250.01 |
2,401,570.95 |
| 基金托管费 |
318,565.91 |
792,806.20 |
392,578.16 |
750,490.89 |
| 销售服务费 |
10,057.98 |
10,024.35 |
4,962.72 |
27,561.31 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
133,782.31 |
395,261.91 |
210,247.62 |
420,459.43 |
| 利润总额 |
-24,701,569.36 |
6,286,614.34 |
12,058,010.27 |
25,123,168.03 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年